Genes involved in predisposition to myelodysplastic syndrome
Cellular function, syndrome, gene . | Inheritance . | Hematologic malignancy . | Other malignancy . | Variable associated phenotypes . |
---|---|---|---|---|
DNA repair | ||||
Fanconi anemia | ||||
FANCA | AR | MDS, AML | Squamous cell carcinoma: oral, gastrointestinal, genitourinary; FANCD1/BRCA2 subtype also presents with other solid tumors and ALL. | Bone marrow failure, short stature, hyper/hypopigmentation, facial dysmorphologies, skeletal, digits, hypogonadism, cardiopulmonary, gastrointestinal, endocrinopathies, CNS |
FANCB | XLR | |||
FANCC | AR | |||
FANCD1/BRCA2 | AR | |||
FANCD2 | AR | |||
FANCE | AR | |||
FANCF | AR | |||
FANCG | AR | |||
FANCI | AR | |||
FANCJ/BRIP1/BACH1 | AR | |||
FANCL | AR | |||
FANCM | AR | |||
FANCN/PALB2 | AR | |||
FANCO/RAD51C | AR | |||
FANCP/SLX4 | AR | |||
FANCQ/ERCC4 | AR | |||
FANCR/RAD51 | AD | |||
FANCS/BRCA1 | AR | |||
FANCT/UBE2T | AR | |||
FANCU/XRCC2 | AR | |||
FANCV/REV7 | AR | |||
FANCW/RFWD3 | AR | |||
Transcription factor | ||||
Familial platelet disorder with propensity to myeloid malignancy | ||||
RUNX1 | AD | MDS, AML, T-ALL, hairy cell leukemia | Thrombocytopenia, platelet dysfunction | |
GATA2-spectrum disorders | ||||
GATA2 | AD | MDS, AML, CMML, JMML | Emberger syndrome, MonoMac syndrome, immunodeficiencies/immune dysregulation (monocytopenia, B-cell deficiencies, NK cell deficiencies), hearing loss, warts, atypical mycobacterial infections, lymphedema, monocytopenia, marrow failure | |
Thrombocytopenia 5 | ||||
ETV6 | AD | ALL, MDS, AML, CMML, MM | Thrombocytopenia, platelet dysfunction | |
Ribosomal abnormalities | ||||
Diamond Blackfan anemia | ||||
GATA1 | AD | MDS, AML | Osteosarcoma, soft tissue sarcomas | Bone marrow failure, short stature, radial ray abnormalities, cardiac, renal anomalies, facial dysmorphisms |
RPL5 | AD | |||
RPL11 | AD | |||
RPL15 | AD | |||
RPL23 | AD | |||
RPL26 | AD | |||
RPL27 | AD | |||
RPL31 | AD | |||
RPL35a | AD | |||
RPL36 | AD | |||
RPS7 | AD | |||
RPS10 | AD | |||
RPS15 | AD | |||
RPS17 | AD | |||
RPS19 | AD | |||
RPS24 | AD | |||
RPS26 | AD | |||
RPS27 | AD | |||
RPS27A | AD | |||
RPS28 | AD | |||
RPS29 | AD | |||
TSR2 | X-linked | |||
Shwachman Diamond syndrome | ||||
SBDS | AR | MDS, AML | Bone marrow failure, short stature, exocrine pancreatic dysfunction, skeletal dysplasias, immunodeficiencies, neurocognitive, other congenital anomalies | |
DNAJC21 | AR | AML | ||
EFL1 | AR | ? | ||
Telomere maintenance | ||||
DC/TBD | ||||
DKC1 | XLR | MDS, AML | Oral and gastrointestinal squamous cell carcinoma | Bone marrow failure, nail dystrophy, skin pigmentation abnormalities, oral leukoplakia, idiopathic pulmonary fibrosis, liver disease, short telomeres, immunodeficiencies, vascular anomalies, other congenital anomalies |
TERC | AD | |||
TERT | AD, AR | |||
NOLA3/NOP10 | AR | |||
NOLA2/NHP2 | AR | |||
TINF2 | AD | |||
WRAP53/TCAB1 | AR | |||
CTC1 | AR | |||
RTEL1 | AD, AR | |||
ACD/ TPP1 | AD, AR | |||
PARN | AD, AR | |||
NAF1 | AD | |||
STN1 | AD | |||
RAS pathway | ||||
Noonan syndrome | ||||
PTPN11, SOS1, RAF1, KRAS, NRAS, BRAF, MAP2K1 | AD | JMML, MDS, AML, MPN | Solid tumors | Facial dysmorphism, short stature, cardiac, broad neck, thoracic, cryptorchidism, coagulopathy (Noonan) |
Noonan-like | ||||
CBL | AD | JMML, MDS | ||
Other | ||||
Severe congenital neutropenia | ||||
ELANE | AD | MDS, AML (ALL?) | Osteopenia | |
HAX1 | AR | MDS, AML (ALL?) | Seizures, neurologic abnormalities | |
GFI1 | AD | MDS, AML | Lymphopenia | |
G6PC3 | AR | MDS, AML | Neutropenia, congenital heart malformations, prominent superficial veins, urogenital abnormalities, Dursun syndrome | |
JAGN1 | AR | AML | Skeletal and dental abnormalities | |
Thrombocytopenia 2 | ||||
ANKRD26 | AD | MDS, AML, CLL, CMML | Thrombocytopenia, platelet dysfunction | |
X-linked neutropenia | ||||
WAS | X-linked | MDS, AML | Immunologic abnormalities, monocytopenia | |
MIRAGE syndrome, (myelodysplasia, infection, restriction of growth, adrenal insufficiency, genital phenotypes, and enteropathy) | ||||
SAMD9 | AD | MDS, AML | Cytopenias, immunologic abnormalities, short stature, adrenal hypoplasia, infections, gastrointestinal, genitourinary skeletal, CNS, monosomy 7 | |
Ataxia-pancytopenia syndrome | ||||
SAMD9L | AD | MDS, AML | Bone marrow failure, ataxia, monosomy 7 | |
Neurofibromatosis 1 | ||||
NF1 | AD | JMML, MDS | Optic gliomas, CNS tumors, malignant peripheral nerve sheath tumors, other solid tumors | Café au lait spots, axillary freckling, Lisch nodules, neurofibromas |
Bloom syndrome | ||||
BLM | AR | Lymphoma, ALL, MDS, AML | Short stature, sun-sensitive rash, pulmonary disease, immunodeficiency | |
Constitutional mismatch repair deficiency | ||||
MLH1 | AR | ALL, Lymphoma, MDS, AML | Gastrointestinal (colon), ovarian, uterine, CNS, other | |
MSH2 | AR | |||
MSH6 | AR | |||
EPCAM | AR | |||
PMS2 | AR | |||
Li-Fraumeni | ||||
TP53 | AD | ALL, MDS, AML, lymphoma | Breast, osteosarcoma, soft tissue sarcoma, CNS, adrenocortical carcinoma, other | |
Susceptibility to acute myeloid leukemia | ||||
DDX41 | AD | MDS, AML, CML, lymphoma | Malignancies present in older age (>50 y) | |
Familial myeloproliferative neoplasms | ||||
JAK2 haplotype 46/1 [GGCC], TERT rs2736100_c | AD | PV, ET, PMF | ||
ATG2B, GSKIP | AD | PV, ET, PMF, CML, CMML, AML | ||
RBBP6 | AD | PV, ET, PMF | ||
Myeloid neoplasms associated with trisomy 8 mosaicism | ||||
Trisomy 8 | Variable | MDS, AML, CML | ||
Congenital neutropenia or SDS-Like disorder | ||||
SRP54 | AR | ? | Bone marrow failure, short stature, exocrine pancreatic dysfunction, skeletal dysplasias, immunodeficiencies | |
Bone Marrow Failure Syndrome 1 | ||||
SRP72 | AD | MDS | Bone marrow failure, sensorineural hearing loss |
Cellular function, syndrome, gene . | Inheritance . | Hematologic malignancy . | Other malignancy . | Variable associated phenotypes . |
---|---|---|---|---|
DNA repair | ||||
Fanconi anemia | ||||
FANCA | AR | MDS, AML | Squamous cell carcinoma: oral, gastrointestinal, genitourinary; FANCD1/BRCA2 subtype also presents with other solid tumors and ALL. | Bone marrow failure, short stature, hyper/hypopigmentation, facial dysmorphologies, skeletal, digits, hypogonadism, cardiopulmonary, gastrointestinal, endocrinopathies, CNS |
FANCB | XLR | |||
FANCC | AR | |||
FANCD1/BRCA2 | AR | |||
FANCD2 | AR | |||
FANCE | AR | |||
FANCF | AR | |||
FANCG | AR | |||
FANCI | AR | |||
FANCJ/BRIP1/BACH1 | AR | |||
FANCL | AR | |||
FANCM | AR | |||
FANCN/PALB2 | AR | |||
FANCO/RAD51C | AR | |||
FANCP/SLX4 | AR | |||
FANCQ/ERCC4 | AR | |||
FANCR/RAD51 | AD | |||
FANCS/BRCA1 | AR | |||
FANCT/UBE2T | AR | |||
FANCU/XRCC2 | AR | |||
FANCV/REV7 | AR | |||
FANCW/RFWD3 | AR | |||
Transcription factor | ||||
Familial platelet disorder with propensity to myeloid malignancy | ||||
RUNX1 | AD | MDS, AML, T-ALL, hairy cell leukemia | Thrombocytopenia, platelet dysfunction | |
GATA2-spectrum disorders | ||||
GATA2 | AD | MDS, AML, CMML, JMML | Emberger syndrome, MonoMac syndrome, immunodeficiencies/immune dysregulation (monocytopenia, B-cell deficiencies, NK cell deficiencies), hearing loss, warts, atypical mycobacterial infections, lymphedema, monocytopenia, marrow failure | |
Thrombocytopenia 5 | ||||
ETV6 | AD | ALL, MDS, AML, CMML, MM | Thrombocytopenia, platelet dysfunction | |
Ribosomal abnormalities | ||||
Diamond Blackfan anemia | ||||
GATA1 | AD | MDS, AML | Osteosarcoma, soft tissue sarcomas | Bone marrow failure, short stature, radial ray abnormalities, cardiac, renal anomalies, facial dysmorphisms |
RPL5 | AD | |||
RPL11 | AD | |||
RPL15 | AD | |||
RPL23 | AD | |||
RPL26 | AD | |||
RPL27 | AD | |||
RPL31 | AD | |||
RPL35a | AD | |||
RPL36 | AD | |||
RPS7 | AD | |||
RPS10 | AD | |||
RPS15 | AD | |||
RPS17 | AD | |||
RPS19 | AD | |||
RPS24 | AD | |||
RPS26 | AD | |||
RPS27 | AD | |||
RPS27A | AD | |||
RPS28 | AD | |||
RPS29 | AD | |||
TSR2 | X-linked | |||
Shwachman Diamond syndrome | ||||
SBDS | AR | MDS, AML | Bone marrow failure, short stature, exocrine pancreatic dysfunction, skeletal dysplasias, immunodeficiencies, neurocognitive, other congenital anomalies | |
DNAJC21 | AR | AML | ||
EFL1 | AR | ? | ||
Telomere maintenance | ||||
DC/TBD | ||||
DKC1 | XLR | MDS, AML | Oral and gastrointestinal squamous cell carcinoma | Bone marrow failure, nail dystrophy, skin pigmentation abnormalities, oral leukoplakia, idiopathic pulmonary fibrosis, liver disease, short telomeres, immunodeficiencies, vascular anomalies, other congenital anomalies |
TERC | AD | |||
TERT | AD, AR | |||
NOLA3/NOP10 | AR | |||
NOLA2/NHP2 | AR | |||
TINF2 | AD | |||
WRAP53/TCAB1 | AR | |||
CTC1 | AR | |||
RTEL1 | AD, AR | |||
ACD/ TPP1 | AD, AR | |||
PARN | AD, AR | |||
NAF1 | AD | |||
STN1 | AD | |||
RAS pathway | ||||
Noonan syndrome | ||||
PTPN11, SOS1, RAF1, KRAS, NRAS, BRAF, MAP2K1 | AD | JMML, MDS, AML, MPN | Solid tumors | Facial dysmorphism, short stature, cardiac, broad neck, thoracic, cryptorchidism, coagulopathy (Noonan) |
Noonan-like | ||||
CBL | AD | JMML, MDS | ||
Other | ||||
Severe congenital neutropenia | ||||
ELANE | AD | MDS, AML (ALL?) | Osteopenia | |
HAX1 | AR | MDS, AML (ALL?) | Seizures, neurologic abnormalities | |
GFI1 | AD | MDS, AML | Lymphopenia | |
G6PC3 | AR | MDS, AML | Neutropenia, congenital heart malformations, prominent superficial veins, urogenital abnormalities, Dursun syndrome | |
JAGN1 | AR | AML | Skeletal and dental abnormalities | |
Thrombocytopenia 2 | ||||
ANKRD26 | AD | MDS, AML, CLL, CMML | Thrombocytopenia, platelet dysfunction | |
X-linked neutropenia | ||||
WAS | X-linked | MDS, AML | Immunologic abnormalities, monocytopenia | |
MIRAGE syndrome, (myelodysplasia, infection, restriction of growth, adrenal insufficiency, genital phenotypes, and enteropathy) | ||||
SAMD9 | AD | MDS, AML | Cytopenias, immunologic abnormalities, short stature, adrenal hypoplasia, infections, gastrointestinal, genitourinary skeletal, CNS, monosomy 7 | |
Ataxia-pancytopenia syndrome | ||||
SAMD9L | AD | MDS, AML | Bone marrow failure, ataxia, monosomy 7 | |
Neurofibromatosis 1 | ||||
NF1 | AD | JMML, MDS | Optic gliomas, CNS tumors, malignant peripheral nerve sheath tumors, other solid tumors | Café au lait spots, axillary freckling, Lisch nodules, neurofibromas |
Bloom syndrome | ||||
BLM | AR | Lymphoma, ALL, MDS, AML | Short stature, sun-sensitive rash, pulmonary disease, immunodeficiency | |
Constitutional mismatch repair deficiency | ||||
MLH1 | AR | ALL, Lymphoma, MDS, AML | Gastrointestinal (colon), ovarian, uterine, CNS, other | |
MSH2 | AR | |||
MSH6 | AR | |||
EPCAM | AR | |||
PMS2 | AR | |||
Li-Fraumeni | ||||
TP53 | AD | ALL, MDS, AML, lymphoma | Breast, osteosarcoma, soft tissue sarcoma, CNS, adrenocortical carcinoma, other | |
Susceptibility to acute myeloid leukemia | ||||
DDX41 | AD | MDS, AML, CML, lymphoma | Malignancies present in older age (>50 y) | |
Familial myeloproliferative neoplasms | ||||
JAK2 haplotype 46/1 [GGCC], TERT rs2736100_c | AD | PV, ET, PMF | ||
ATG2B, GSKIP | AD | PV, ET, PMF, CML, CMML, AML | ||
RBBP6 | AD | PV, ET, PMF | ||
Myeloid neoplasms associated with trisomy 8 mosaicism | ||||
Trisomy 8 | Variable | MDS, AML, CML | ||
Congenital neutropenia or SDS-Like disorder | ||||
SRP54 | AR | ? | Bone marrow failure, short stature, exocrine pancreatic dysfunction, skeletal dysplasias, immunodeficiencies | |
Bone Marrow Failure Syndrome 1 | ||||
SRP72 | AD | MDS | Bone marrow failure, sensorineural hearing loss |
AD, autosomal dominant; AR, autosomal recessive; CMML, chronic myelomonocytic leukemia; ET, essential thrombocythemia; JMML, juvenile myelomonocytic leukemia; PMF, primary myelofibrosis; PV, polycythemia vera.
Because of space limitations, this table is not exhaustive and readers are referred to additional references cited in the text.